KCNJ11 and Hypoinsulinemia: Conversely, gain-of-function mutations of Kir6.2 or SUR1 are expected to cause an undersecreting phenotype and hypoinsulinemia—and consistent with this prediction, activating mutations in KATP cause both permanent and transient neonatal diabetes [44,45].